A detailed history of Advisor Group Holdings, Inc. transactions in Kamada LTD stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,000 shares of KMDA stock, worth $7,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 100 900.0%
Holding current value
$7,210
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

BUY
$6.33 - $8.33 $5,697 - $7,497
900 Added 900.0%
1,000 $6,000
Q4 2024

Jun 06, 2025

SELL
$5.17 - $6.27 $4,653 - $5,643
-900 Reduced 90.0%
100 $0
Q1 2022

May 04, 2022

SELL
$5.43 - $6.81 $1,629 - $2,042
-300 Reduced 75.0%
100 $1,000
Q4 2020

Feb 10, 2021

SELL
$6.3 - $8.46 $1,215 - $1,632
-193 Reduced 32.55%
400 $3,000
Q3 2020

Nov 12, 2020

SELL
$8.02 - $11.73 $8,541 - $12,492
-1,065 Reduced 64.23%
593 $6,000
Q1 2020

May 18, 2020

BUY
$4.56 - $7.13 $7,560 - $11,821
1,658 New
1,658 $10,000

Others Institutions Holding KMDA

About KAMADA LTD


  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $323M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.